http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-05815687-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-81
filingDate 2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019e2e24f5c9e6f15d5b31f3fc7c56d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71e559a7929f0651c8b72bcb8fa9788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f387c79a0591081cc4e597fb59abddcd
publicationDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-05815687-T1
titleOfInvention PROCESS FOR PREPARING CITALOPRAM AND ENANTIOMERS
abstract A process for the preparation of 1- [3- (dimethylamino) propyl] -1- (4-fluorophenyl) -1,3-dihydro-5-isobenzofurancarbonitrile which comprises reacting a compound of formula IVa in the presence of a base with a compound of Formula RX, Formula IVa wherein R is selected from alkyl, alkenyl, aryl and heteroaryl, which may be optionally substituted with electron-withdrawing groups, and X is selected from F, Cl, Br, I, CN, OTf and OR 1 , wherein Tf is a trifluoromethanesulfonyl R 1 is optionally substituted alkyl, Z is a cyano group or a group which can be converted to a cyano group; wherein RX is selected such that an ether derivative obtained as an intermediate, a compound of formula Va formed by the reaction, cyclizes to a compound of formula VI, Formula Va Formula VI and wherein Z is not a cyano group, and converting the group Z in the compound of the formula VI into a cyano group to give 1- [3- (dimethylamino) propyl] -1- (4-fluorophenyl) 1,3-dihydro-5-isobenzofurancarbonitrile.
priorityDate 2004-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426139038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426155573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11612980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422007404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7472057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466721983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467831157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10132164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422527974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734677

Total number of triples: 36.